Cardiac hypertrophy is a main contributor to heart failure, where therapeutic options are limited. Increasing evidence exists ...

Medtronic plc expects its Hugo robotic-assisted surgery system to be a key growth driver, especially when it receives U.S.

The U.K. National Institute for Health and Care Excellence has recommended that physicians in the U.K. use the least ...

Deficiencies in interferon-stimulated gene 15 (ISG15), a protein that normally regulates the immune response, causes mild but ...

The U.S. FDA has cleared Artrya Ltd.’s 510(k) for its Salix coronary plaque (SCP) module that is a bolt-on module to the ...

Shattuck Labs Inc. has reported that its IND from the U.S. FDA for SL-325 for the treatment of inflammatory bowel disease is ...

Aclarion Inc.'s Nociscan, an AI-augmented platform that leverages MR spectroscopy to noninvasively identify the discs causing low-back pain, enables precise targeting of surgical intervention, ...

Multiple datasets are due to roll out soon in the Prader-Willi syndrome (PWS) space, where contenders are trying varied mechanisms of action to tackle the rare genetic disorder characterized by ...

The U.S. FDA approved 17 drugs in July, down from 23 in June, bringing the year-to-date total to 125. Through July, 2025 remains the third-highest count in BioWorld’s records, trailing 135 approvals ...

Negotiations between the U.K. government and the pharmaceutical industry have broken down with no agreement over the level of rebates companies must pay back to the government under the current ...

An investigation of the epidemiology and clinical characteristics of neuropathic pain in the UK Biobank has led to the ...

Researchers at Université de Montréal and collaborators have succeeded in preparing a highly immunogenic SARS-CoV-2 vaccine using the Accum platform.